0HVB Stock Chart & Stats
$61.70
-$1.56(-2.47%)
At close: 4:00 PM EDT
$61.70
-$1.56(-2.47%)
Day’s Range― - ―
52-Week Range$30.91 - $72.41
Previous CloseN/A
Volume1.11K
Average Volume (3M)5.17K
Market Cap
$34.70B
Enterprise Value$48.14B
Total Cash (Recent Filing)$27.06B
Total Debt (Recent Filing)$16.11B
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Oct 27, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend Yield0.33%
Share Statistics
EPS (TTM)-10.40
Shares Outstanding493,995,000
10 Day Avg. Volume3,705
30 Day Avg. Volume5,173
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.01
Price to Sales (P/S)0.10
P/FCF Ratio4.68
Enterprise Value/Market Cap1.39
Enterprise Value/Revenue0.25
Enterprise Value/Gross Profit1.54
Enterprise Value/Ebitda-17.63
Forecast
1Y Price Target
$72.92Price Target Upside18.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
EPS Forecast (FY)4.87
Revenue Forecast (FY)$196.55B
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation And Improving LeverageStrong operating cash flow provides internal funding for claims, investment and capital allocation even while reported earnings have been pressured. Lower debt-to-capital and senior-note repayments further improve financial flexibility, making the balance sheet more resilient over the next several quarters.
Margin Recovery And Higher Earnings OutlookImproving health benefits and administrative expense ratios indicate better medical-cost management and operating discipline across major segments. The raised earnings outlook supports a durable recovery thesis, although continued execution will be needed to convert recent improvement into sustainable profitability.
Debt Profile SimplificationEliminating the remaining 2027 notes simplifies Centene’s maturity profile and reduces a defined refinancing obligation. Combined with prior note repurchases, this action can strengthen balance-sheet flexibility and give management more room to direct future cash toward operations and strategic priorities.
Bears Say
Recent Profitability DeteriorationThe recent swing to operating and net losses weakens earnings quality and reduces confidence that current cash generation will consistently translate into shareholder returns. Negative TTM profitability also limits financial resilience if medical costs remain elevated or enrollment trends deteriorate further.
Medicaid Membership Attrition And Acuity RiskLower Medicaid enrollment can reduce the scale of Centene’s largest operating franchise, while higher acuity among remaining members may increase claims costs. Together, these trends could offset rate increases and make margin restoration more dependent on precise pricing and utilization management.
Persistent Medical-cost PressureElevated spending in behavioral health, home health and specialty drugs creates ongoing pressure on medical benefit ratios across the portfolio. If these cost categories remain above pricing assumptions, they could erode the recent margin gains and require additional rate, utilization or benefit actions.
Centene News
0HVB FAQ
What was Centene’s price range in the past 12 months?
Centene lowest share price was $30.91 and its highest was $72.41 in the past 12 months.
What is Centene’s market cap?
Centene’s market cap is $34.70B.
When is Centene’s upcoming earnings report date?
Centene’s upcoming earnings report date is Oct 27, 2026 which is in 4 days.
How were Centene’s earnings last quarter?
Centene released its earnings results on Jul 28, 2026. The company reported $2.51 earnings per share for the quarter, beating the consensus estimate of $1.085 by $1.425.
Is Centene overvalued?
According to Wall Street analysts Centene’s price is currently Undervalued.
Does Centene pay dividends?
Centene pays a Notavailable dividend of $0.285 which represents an annual dividend yield of 0.33%. See more information on Centene dividends here
What is Centene’s EPS estimate?
Centene’s EPS estimate is 0.1.
How many shares outstanding does Centene have?
Centene has 493,995,000 shares outstanding.
What happened to Centene’s price movement after its last earnings report?
Centene reported an EPS of $2.51 in its last earnings report, beating expectations of $1.085. Following the earnings report the stock price went down -1.709%.
Which hedge fund is a major shareholder of Centene?
Currently, no hedge funds are holding shares in GB:0HVB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Centene Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$72.92 (18.19% Upside)
$72.92 (18.19% Upside)
Blogger Sentiment
Bullish
GB:0HVB Sentiment 82%
Sector Average 66%
Sector Average 66%
Insider Transactions
Sold Shares
Worth $6.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
97.77%
12-Months-Change
Fundamentals
Return on Equity
-24.03%
Trailing 12-Months
Asset Growth
-3.92%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Centene
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
0HVB Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid financial momentum and tangible operational progress: a Q2 EPS beat, raised full-year EPS guidance, margin improvements in Marketplace and PDP, better-than-expected state rate development for Medicaid, strong cash flow and balance-sheet improvements, and measurable cost-management wins (including AI-enabled initiatives). However, the company faces meaningful near-term headwinds: membership attrition (especially in Medicaid expansion), acuity shifts that could pressure medical cost ratios, regulatory/program uncertainty (OB3, STARS, eligibility verification), and a portion of Q2 upside tied to nonrecurring prior-period settlements. On balance, the positive guidance revisions, margin recoveries in key segments, cash and debt improvement, and demonstrated operating discipline outweigh the near-term risks flagged by management.View all GB:0HVB earnings summaries0HVB Revenue Breakdown
88.08% Premium
1.55% Service
10.37% Premium tax
0HVB Stock 12 Month Forecast
Average Price Target
$72.92
▲(18.19% Upside)